3D printed bilayer mucoadhesive buccal film of estradiol: Impact of design on film properties, release kinetics and predicted in vivo performance
- PMID: 36280219
- DOI: 10.1016/j.ijpharm.2022.122324
3D printed bilayer mucoadhesive buccal film of estradiol: Impact of design on film properties, release kinetics and predicted in vivo performance
Abstract
Despite being an effective therapy for menopausal symptoms, the use of oral estrogen is associated with low bioavailability and serious adverse effects of venous thromboembolism. Individualized therapy has been recommended to maximize benefits and curb the adverse effects, but much has not been done in developing formulations that offer flexibility to personalize therapy. In the present study, we employed an innovative 3D printing technology to design and develop bi-layered estradiol film with different infill patterns with an aim of improving bioavailability and facilitating personalized treatment. Hydroxypropyl cellulose (HPC-H) based formulation exhibited suitable rheological properties and was used as a feedstock to fabricate estradiol films with different infill patterns namely honeycomb, rectangular and plain. The back layer was prepared from a hydroxyethyl cellulose-based formulation. The resulting films were subsequently characterized in terms of their physicochemical, mechanical, environmental impact, and release characteristics among others. Films with a plain infill pattern exhibited significantly higher % elongation break and tensile strength. The in vitro drug release study revealed the fastest drug release profile for rectangular infill (96 % within 4 h) and the slowest drug release was observed for the plain infill pattern (∼35 % within 4 h), highlighting the effect of the infill pattern on release kinetics. Films with honeycomb infill patterns were selected for further characterization based on mechanical and in vitro release properties. No interaction between components of the formulation was observed and the absence of crystallinity in the final product was confirmed by Differential Scanning Calorimetry (DSC) and X-Ray Powder Diffraction analyses (XRD). The force of adhesiveness for the film was 0.13 ± 0.03 N. The predicted AUC 0-4 h, Cmax, and Tmax were 144.85 ng·h/mL, 65.97 ng/mL, and 0.83 h for a film (honeycomb infill pattern) loaded with 1 mg of estradiol. The printing process of films with honeycomb and rectangular infill patterns was evaluated as "green" using the index of Greenness Assessment of Printed Pharmaceuticals (iGAPP) tool. Our finding demonstrates the development of bi-layered estradiol film using Pressure assisted microsyringe (PAM) 3D printing and the influence of infill patterns on release kinetics and mechanical properties. The fabricated film not only facilitates the move towards personalized medicine but could also improve the bioavailability of the drugs by bypassing the hepatic first-pass metabolism and decreasing wash-out by the saliva.
Keywords: Estradiol bi-layered film; In vivo prediction; Infill patterns; Pressure-assisted microsyringe; Release kinetics.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.Int J Pharm. 2021 Dec 15;610:121261. doi: 10.1016/j.ijpharm.2021.121261. Epub 2021 Nov 4. Int J Pharm. 2021. PMID: 34742830
-
Development of Tizanidine HCl-Meloxicam loaded mucoadhesive buccal films: In-vitro and in-vivo evaluation.PLoS One. 2018 Mar 22;13(3):e0194410. doi: 10.1371/journal.pone.0194410. eCollection 2018. PLoS One. 2018. PMID: 29566073 Free PMC article.
-
Mucoadhesive Buccal Film of Estradiol for Hormonal Replacement Therapy: Development and In-Vivo Performance Prediction.Pharmaceutics. 2022 Feb 28;14(3):542. doi: 10.3390/pharmaceutics14030542. Pharmaceutics. 2022. PMID: 35335917 Free PMC article.
-
Immediate release 3D printed oral dosage forms: How different polymers have been explored to reach suitable drug release behaviour.Int J Pharm. 2022 Sep 25;625:122066. doi: 10.1016/j.ijpharm.2022.122066. Epub 2022 Aug 1. Int J Pharm. 2022. PMID: 35926751 Review.
-
3D printing: An appealing route for customized drug delivery systems.Int J Pharm. 2020 Oct 15;588:119732. doi: 10.1016/j.ijpharm.2020.119732. Epub 2020 Aug 5. Int J Pharm. 2020. PMID: 32768528 Review.
Cited by
-
The Potential of Films as Transmucosal Drug Delivery Systems.Pharmaceutics. 2023 Nov 4;15(11):2583. doi: 10.3390/pharmaceutics15112583. Pharmaceutics. 2023. PMID: 38004562 Free PMC article. Review.
-
Design and Development of Sublingual Printlets Containing Domperidone Nanocrystals Using 3D Melting Solidification Printing Process (MESO-PP).Pharmaceutics. 2023 May 10;15(5):1459. doi: 10.3390/pharmaceutics15051459. Pharmaceutics. 2023. PMID: 37242699 Free PMC article.
-
Characteristics, preparation and applicability in oral delivery systems of cellulose ether-based buccal films.Drug Deliv. 2025 Dec;32(1):2525223. doi: 10.1080/10717544.2025.2525223. Epub 2025 Jul 11. Drug Deliv. 2025. PMID: 40641388 Free PMC article. Review.
-
Preparation and In Vitro Evaluation of Montelukast Sodium-Loaded 3D Printed Orodispersible Films for the Treatment of Asthma.AAPS PharmSciTech. 2024 Sep 17;25(7):218. doi: 10.1208/s12249-024-02938-z. AAPS PharmSciTech. 2024. PMID: 39289238
-
Combining the potential of 3D printed buccal films and nanostructured lipid carriers for personalised cannabidiol delivery.Drug Deliv Transl Res. 2024 Apr;14(4):984-1004. doi: 10.1007/s13346-023-01446-0. Epub 2023 Oct 30. Drug Deliv Transl Res. 2024. PMID: 37903964 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous